Peter Adam Hochfelder increased its stake in Oracle Corp (ORCL) by 61.3% based on its latest 2017Q3 regulatory filing with the SEC. Brahman Capital Corp bought 1.47 million shares as the company’s stock rose 5.35% with the market. The hedge fund run by Peter Adam Hochfelder held 3.87M shares of the prepackaged software company at the end of 2017Q3, valued at $187.14M, up from 2.40 million at the end of the previous reported quarter. Brahman Capital Corp who had been investing in Oracle Corp for a number of months, seems to be bullish on the $209.92B market cap company. The stock increased 0.14% or $0.07 during the last trading session, reaching $50.71. About 11.10 million shares traded. Oracle Corporation (NYSE:ORCL) has risen 14.08% since February 17, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Krensavage Asset Management Llc decreased its stake in Gilead Sciences Inc (GILD) by 2.16% based on its latest 2017Q3 regulatory filing with the SEC. Krensavage Asset Management Llc sold 11,510 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 520,924 shares of the health care company at the end of 2017Q3, valued at $42.21 million, down from 532,434 at the end of the previous reported quarter. Krensavage Asset Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $105.42 billion market cap company. The stock decreased 1.04% or $0.85 during the last trading session, reaching $80.7. About 7.55 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 17, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 38 analysts covering Oracle (NYSE:ORCL), 28 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Oracle had 105 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was upgraded by SunTrust on Wednesday, September 16 to “Buy”. The company was maintained on Thursday, December 17 by FBR Capital. The stock of Oracle Corporation (NYSE:ORCL) earned “Outperform” rating by RBC Capital Markets on Friday, September 30. Goldman Sachs maintained the shares of ORCL in report on Wednesday, March 16 with “Buy” rating. The rating was maintained by BMO Capital Markets on Thursday, March 16 with “Outperform”. RBC Capital Markets maintained the shares of ORCL in report on Sunday, July 23 with “Buy” rating. RBC Capital Markets maintained Oracle Corporation (NYSE:ORCL) on Thursday, June 22 with “Outperform” rating. The stock of Oracle Corporation (NYSE:ORCL) has “Buy” rating given on Thursday, February 15 by Piper Jaffray. The firm has “Buy” rating by BMO Capital Markets given on Wednesday, August 16. The rating was maintained by BMO Capital Markets on Friday, September 16 with “Outperform”.

Brahman Capital Corp, which manages about $4.97B and $2.94B US Long portfolio, decreased its stake in Ihs Markit Ltd by 567,598 shares to 4.26M shares, valued at $187.84M in 2017Q3, according to the filing. It also reduced its holding in Quintiles Ims Holdings Inc (NYSE:Q) by 231,109 shares in the quarter, leaving it with 4.30M shares, and cut its stake in Sealed Air Corp New (NYSE:SEE).

Since August 30, 2017, it had 0 buys, and 13 insider sales for $51.09 million activity. Washington Robin L sold $4.40M worth of stock or 51,820 shares. The insider Alton Gregg H sold $2.08M. 60,000 shares were sold by Meyers James R, worth $4.99M.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Market Perform” rating by Leerink Swann given on Thursday, October 19. The rating was maintained by Mizuho on Tuesday, July 25 with “Buy”. The company was maintained on Wednesday, October 4 by Bank of America. The stock has “Neutral” rating by Credit Suisse on Wednesday, December 20. The stock has “Buy” rating by Gabelli on Wednesday, June 1. Morgan Stanley maintained the stock with “Equal-Weight” rating in Friday, October 6 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Maxim Group on Monday, August 28. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Friday, October 27. The rating was maintained by BMO Capital Markets on Wednesday, February 7 with “Hold”. The rating was maintained by Mizuho with “Buy” on Thursday, September 28.

Krensavage Asset Management Llc, which manages about $60.40 million and $320.80M US Long portfolio, upped its stake in United Therapeutics Corp (NASDAQ:UTHR) by 73,515 shares to 346,511 shares, valued at $40.61 million in 2017Q3, according to the filing.